These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

192 related articles for article (PubMed ID: 16218931)

  • 41. Overexpression of GRP78 and GRP94 are markers for aggressive behavior and poor prognosis in gastric carcinomas.
    Zheng HC; Takahashi H; Li XH; Hara T; Masuda S; Guan YF; Takano Y
    Hum Pathol; 2008 Jul; 39(7):1042-9. PubMed ID: 18482745
    [TBL] [Abstract][Full Text] [Related]  

  • 42. TGFbeta1, TGFbeta2, and TGFbeta3 protein expression in gastric carcinomas: correlation with prognostics factors and patient survival.
    Vagenas K; Spyropoulos C; Gavala V; Tsamandas AC
    J Surg Res; 2007 May; 139(2):182-8. PubMed ID: 17270215
    [TBL] [Abstract][Full Text] [Related]  

  • 43. Approach to the diagnosis of neuroendocrine lung neoplasms: variabilities and pitfalls.
    Hammar SP
    Semin Thorac Cardiovasc Surg; 2006; 18(3):183-90. PubMed ID: 17185177
    [TBL] [Abstract][Full Text] [Related]  

  • 44. Arp2/3 overexpression contributed to pathogenesis, growth and invasion of gastric carcinoma.
    Zheng HC; Zheng YS; Li XH; Takahashi H; Hara T; Masuda S; Yang XH; Guan YF; Takano Y
    Anticancer Res; 2008; 28(4B):2225-32. PubMed ID: 18751399
    [TBL] [Abstract][Full Text] [Related]  

  • 45. Natural history, clinicopathologic classification and prognosis of gastric ECL cell tumors.
    Solcia E; Rindi G; Paolotti D; Luinetti O; Klersy C; Zangrandi A; La Rosa S; Capella C
    Yale J Biol Med; 1998; 71(3-4):285-90. PubMed ID: 10461359
    [TBL] [Abstract][Full Text] [Related]  

  • 46. [Correlation of E-cadherin hypermethylation to tumorigenesis and development of gastric cancer].
    Liu WT; Jiao HL; Yang YL; Wang D; Zhang WM
    Ai Zheng; 2007 Nov; 26(11):1199-203. PubMed ID: 17991318
    [TBL] [Abstract][Full Text] [Related]  

  • 47. Differential expression of EphA7 receptor tyrosine kinase in gastric carcinoma.
    Wang J; Li G; Ma H; Bao Y; Wang X; Zhou H; Sheng Z; Sugimura H; Jin J; Zhou X
    Hum Pathol; 2007 Nov; 38(11):1649-56. PubMed ID: 17669470
    [TBL] [Abstract][Full Text] [Related]  

  • 48. p53 is an indicator of tumor progression in early but not advanced gastric carcinomas.
    Ishii HH; Gobe GC; Ebihara Y
    Hepatogastroenterology; 2007; 54(79):2159-63. PubMed ID: 18251181
    [TBL] [Abstract][Full Text] [Related]  

  • 49. The value of the immunohistochemistry in a case of gastric neuroendocrine tumor and thyroid metastasis.
    Poiană C; Carşote M; Ardeleanu C; Terzea D; Avramescu ET; Neamţu MC; Miulescu RD
    Rom J Morphol Embryol; 2011; 52(1):187-92. PubMed ID: 21424054
    [TBL] [Abstract][Full Text] [Related]  

  • 50. Presence of poorly differentiated component correlated with submucosal invasion in the early diffuse-type gastric cancer.
    Kuroda T; Ito M; Wada Y; Kitadai Y; Tanaka S; Yoshida K; Yoshihara M; Haruma K; Merdh S; Chayama K
    Hepatogastroenterology; 2008; 55(88):2264-8. PubMed ID: 19260519
    [TBL] [Abstract][Full Text] [Related]  

  • 51. Accumulation of DNA methylation is associated with tumor stage in gastric cancer.
    Oue N; Mitani Y; Motoshita J; Matsumura S; Yoshida K; Kuniyasu H; Nakayama H; Yasui W
    Cancer; 2006 Mar; 106(6):1250-9. PubMed ID: 16475210
    [TBL] [Abstract][Full Text] [Related]  

  • 52. Gastric cancer: correlation between clinicopathological factors and survival of patients. II.
    Lazăr D; Tăban S; Sporea I; Dema A; Cornianu M; Lazăr E; Goldiş A; Vernic C
    Rom J Morphol Embryol; 2009; 50(2):185-94. PubMed ID: 19434309
    [TBL] [Abstract][Full Text] [Related]  

  • 53. Mucinous gastric carcinomas: clinicopathologic and molecular analyses.
    Choi JS; Kim MA; Lee HE; Lee HS; Kim WH
    Cancer; 2009 Aug; 115(15):3581-90. PubMed ID: 19479974
    [TBL] [Abstract][Full Text] [Related]  

  • 54. Mixed-histologic-type submucosal invasive gastric cancer as a risk factor for lymph node metastasis: feasibility of endoscopic submucosal dissection.
    Hanaoka N; Tanabe S; Mikami T; Okayasu I; Saigenji K
    Endoscopy; 2009 May; 41(5):427-32. PubMed ID: 19418397
    [TBL] [Abstract][Full Text] [Related]  

  • 55. Aberrant expression of cortactin and fascin are effective markers for pathogenesis, invasion, metastasis and prognosis of gastric carcinomas.
    Li X; Zheng H; Hara T; Takahashi H; Masuda S; Wang Z; Yang X; Guan Y; Takano Y
    Int J Oncol; 2008 Jul; 33(1):69-79. PubMed ID: 18575752
    [TBL] [Abstract][Full Text] [Related]  

  • 56. Immunohistochemical expression of the human sodium/iodide symporter distinguishes malignant from benign gastric lesions.
    Farnedi A; Eusebi LH; Poli F; Foschini MP
    Int J Surg Pathol; 2009 Aug; 17(4):327-34. PubMed ID: 19124451
    [TBL] [Abstract][Full Text] [Related]  

  • 57. [APUD cells in gastric cancer].
    Nogueira AM; Barbosa AJ
    Arq Gastroenterol; 1986; 23(4):223-8. PubMed ID: 2894823
    [TBL] [Abstract][Full Text] [Related]  

  • 58. Clinicopathologic characteristics and surgical outcomes of mucinous gastric carcinoma.
    Kunisaki C; Akiyama H; Nomura M; Matsuda G; Otsuka Y; Ono HA; Shimada H
    Ann Surg Oncol; 2006 Jun; 13(6):836-42. PubMed ID: 16604474
    [TBL] [Abstract][Full Text] [Related]  

  • 59. CpG island methylation as an early event during adenoma progression in carcinogenesis of sporadic colorectal cancer.
    Kim HC; Roh SA; Ga IH; Kim JS; Yu CS; Kim JC
    J Gastroenterol Hepatol; 2005 Dec; 20(12):1920-6. PubMed ID: 16336454
    [TBL] [Abstract][Full Text] [Related]  

  • 60. [Gastric cancer: histological type, histogenesis, and gene abnormalities].
    Tamura G
    Gan To Kagaku Ryoho; 2008 Feb; 35(2):343-9. PubMed ID: 18281780
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 10.